Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy

Journal of Clinical Virology

Volumn 33, Issue 3, 2005, Pages 194-200

  Vitone, Francesca ^a   Gibellini, Davide ^a   Schiavone, Pasqua ^a   Re, Maria Carla ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

HIV 1 proviral DNA; Real time PCR; Therapy; Viral load RNA

Indexed keywords

BIOLOGICAL MARKER; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS DNA;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MONITOR; OBSERVATION; PERIPHERAL LYMPHOCYTE; PLASMA; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY; T LYMPHOCYTE; VIREMIA; VIRUS DETECTION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; POLYMERASE CHAIN REACTION; PROVIRUSES; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VIRAL LOAD;

EID: 19344378595     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.11.003     Document Type: Article

References (37)

1. J. Boni, C. Shah, M. Flepp, R. Luthy, and J. Schupbach Detection of low copy numbers of HIV-1 proviral DNA in patient PBMCs by a high-input, sequence-capture PCR (Mega-PCR) J Med Virol 72 2004 1 9
2. C. Brostrom, U. Visco-Comandini, Z. Yun, and A. Sonnerborg Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors J Infect Dis 179 1999 1542 1548
3. F. Brun-Vezinet, C. Boucher, C. Loveday, D. Descamps, V. Fauveau, J. Izopet The National Virology Groups. Delta Virology Working Group and Coordinating Committee HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial Lancet 350 1997 983 990
4. C. Christopherson, Y. Kidane, B. Conway, J. Krowka, H. Sheppard, and S. Kwok PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells J Clin Microbiol 38 2000 630 634
5. T.W. Chun, L. Carruth, D. Finzi, X. Shen, J.A. DiGiuseppe, and H. Taylor Quantification of latent tissue reservoirs and total body viral load in HIV infection Nature 387 1997 183 188
6. T.W. Chun, and A.S. Fauci Latent reservoirs of HIV: obstacles to the eradication of virus Proc Natl Acad Sci U S A 96 1999 10958 10961
7. + T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy J Infect Dis 185 2002 1672 1676
8. M. Clementi, S. Menzo, P. Bagnarelli, A. Valenza, S. Paolucci, and R. Sampaolesi Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection Clin Microbiol Rev 9 1996 135 147
9. N. Desirè, A. Dehee, V. Schneider, C. Jacomet, C. Goujon, and P.M. Girard Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay J Clin Microb 39 2001 1303 1310
10. D. Finzi, M. Hermankova, T. Pierson, L.M. Carruth, C. Buck, and R.E. Chaisson Identification of a reservoir for HIV in patients on highly active antiretroviral therapy Science 278 1997 1295 1300
11. M.R. Furtado, D.S. Callaway, J.P. Phair, K.J. Kunstman, J.L. Stanton, and C.A. Macken Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy N Engl J Med 340 1999 1614 1622
12. D. Gibellini, F. Vitone, P. Schiavone, C. Ponti, M. La Placa, and M.C. Re Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique J Clin Virol 29 2004 282 289
13. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, March 23, 2004, available at: http://www.aidsinfo.nih.gov.
14. P. Gupta, M. Ding, M. Cottrill, C. Rinaldo, L. Kingsley, and S. Wolinsky Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay J Clin Microbiol 33 1995 1670 1673
15. B. Hoen, B. Dumon, M. Harzic, A. Venet, B. Dubeaux, and C. Lascoux Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trial J Infect Dis 180 1999 1342 1346
16. A. Ibanez, T. Puig, J. Elias, B. Clotet, L. Ruiz, and M.A. Martinez Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients AIDS 13 1999 1045 1049
17. J. Izopet, C. Tamalet, C. Pasquier, K. Sandres, B. Marchou, and P. Massip Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay J Med Virol. 54 1998 54 59
18. L.G. Kostrikis, G. Touloumi, R. Karanicolas, N. Pantazis, C. Anastassopoulou, A. Karafoulidou Multicenter Hemophilia Cohort Study Group Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load J Virol 76 2002 10099 10108
19. A. Lafeuillade, C. Poggi, S. Chadapaud, G. Hittinger, H. Khiri, and P. Halfon Impact of immune interventions on proviral HIV-1 DNA decay in patients receiving highly active antiretroviral therapy HIV Med 2 2001 189 194
20. E. Lalli, D. Gibellini, S. Santi, and A. Facchini In situ hybridization in suspension and flow cytometry as a tool for the study of gene expression Anal. Biochem. 207 1992 298 303
21. F. Mallet, C. Hebrard, J.M. Livrozet, O. Lees, F. Tron, and J.L. Touraine Quantitation of human immunodeficiency virus type 1 DNA by two PCR procedures coupled with enzyme-linked oligosorbent assay J Clin Microbiol 33 1995 3201 3208
22. J.L. McDermott, A.A. Giri, I. Martini, M. Bono, M. Giacomini, and A. Campelli Level of human immunodeficiency virus DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy J Clin Microbiol 37 1999 2361 2365
23. A. Mocroft, S. Vella, T.L. Benfield, A. Chiesi, V. Miller, P. Gargalianos EuroSIDA Study Group Changing patterns of mortality across Europe in patients infected with HIV-1 Lancet 352 1998 1725 1730
24. V. Natarajan, M. Bosche, J.A. Metcalf, D.J. Ward, H.C. Lane, and J.A. Kovacs HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy Lancet 353 1999 119 120
25. N. Ngo-Giang-Huong, C. Deveau, I. Da Silva, I. Pellegrin, A. Venet, M. Harzic Frnech PRIMO Cohort Study Group Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy AIDS 15 2001 665 673
26. F.J. Palella Jr., K.M. Delaney, A.C. Moorman, M.O. Loveless, J. Fuhrer, and G.A. Satten Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N Engl J Med 338 1998 853 860
27. A.S. Perelson, A.U. Neumann, M. Markowitz, J.M. Leonard, and D.D. Ho HIV dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time Science 271 1996 1582 1586
28. S.P. Perfetto, and G. McCrary Immunophenotyping and assessment of cell function by three-color flow cytometry of peripheral blood lymphocytes N. Michael J.H. Kim HIV protocols 1999 Humana Press Totowa, NJ pp. 397-407
29. M.C. Re, D. Gibellini, G. Furlini, M. Vignoli, F. Vitone, and I. Bon Relationships between the presence of anti-Tat antibody, DNA and RNA viral load New Microbiol 24 2001 207 215
30. E. Riva, M. Pistello, P. Narciso, G. D'Offizi, P. Isola, and V. Galati Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy AIDS Res Hum Retroviruses 17 2001 1599 1604
31. E. Riva, G. Antonelli, C. Scagnolari, M. Pistello, M.R. Capobianchi, A. Monforte I.C.O.N.A. Study Group Human immunodeficiency virus (HIV) DNA load and level of immunosuppression in treatment-naive HIV-1-infected patients J Infect Dis 187 2003 1826 1828
32. B. Shiramizu, S. Gartner, M. Cho, Y. Liu, N. Pyron, and V. Valcour Assessment of HIV-1 DNA copies per cell by real-time polymerase chain reaction Front Biosci 9 2004 255 261
33. C. Tierney, J.L. Lathey, C. Christopherson, D.M. Bettendorf, R.T. D'Aquila, and S.M. Hammer Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy J Infect Dis 187 2003 144 148
34. E. Vittinghoff, S. Scheer, P. O'Malley, G. Colfax, S.D. Holmberg, and S.P. Buchbinder Combination antiretroviral therapy and recent declines in AIDS incidence and mortality J Infect Dis 179 1999 717 720
35. X. Wei, S.K. Ghosh, M.E. Taylor, V.A. Johnson, E.A. Emini, and P. Deutsch Viral dynamics in human immunodeficiency virus type 1 infection Nature 373 1995 117 122
36. J.K. Wong, M. Hezareh, H.F. Gunthard, D.V. Havlir, C.C. Ignacio, and C.A. Spina Recovery of replication-competent HIV despite prolonged suppression of plasma viremia Science 278 1997 1291 1295
37. L. Zhang, B. Ramratnam, K. Tenner-Racz, Y. He, M. Vesanen, and S. Lewin Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy N Engl J Med 27 340 1999 1605 1613